Company Info
Medexus Pharmaceuticals Inc. is a Canadian specialty pharmaceutical company focused on the development, licensing, and commercialization of innovative and rare disease treatments. Established in 2018, the company has grown to provide a diverse portfolio of prescription medications across North America, addressing critical unmet medical needs in areas such as rheumatology, hematology, and autoimmune diseases. Medexus is publicly traded on the Toronto Stock Exchange under the ticker symbol MDP. The company’s headquarters is located in Canada, where it manages its operations, partnerships, and product distribution. With a commitment to patient care and medical innovation, Medexus continues to expand its presence in the pharmaceutical industry by bringing high-quality and effective treatments to market. The company focuses on long-term growth by identifying promising therapies, securing strategic acquisitions, and maintaining strong relationships with healthcare providers to ensure that patients receive the best possible care.